|
|
Volumn 2012, Issue , 2012, Pages 230-236
|
|
Haploidentical transplantation for hematologic malignancies: where do we stand?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
HLA ANTIGEN;
ALLELE;
CHEMISTRY;
CYTOLOGY;
DONOR;
FEMALE;
HEMATOLOGIC DISEASE;
HISTOCOMPATIBILITY;
HUMAN;
IMMUNE SYSTEM;
IMMUNOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
LYMPHOCYTE;
MALE;
METHODOLOGY;
REGULATORY T LYMPHOCYTE;
REVIEW;
STEM CELL;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TREATMENT OUTCOME;
ALLELES;
CYCLOPHOSPHAMIDE;
FEMALE;
HEMATOLOGIC NEOPLASMS;
HISTOCOMPATIBILITY;
HLA ANTIGENS;
HUMANS;
IMMUNE SYSTEM;
LYMPHOCYTES;
MALE;
STEM CELL TRANSPLANTATION;
STEM CELLS;
T-LYMPHOCYTES;
T-LYMPHOCYTES, REGULATORY;
TISSUE DONORS;
TRANSPLANTATION CONDITIONING;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 84879357432
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation.v2012.1.230.3798312 Document Type: Review |
|
Times cited : (60)
|
|
References (0)
|
